Fortifying the barrier: The impact of lipid A remodelling on bacterial pathogenesis

Nature Reviews Microbiology

Volumn 11, Issue 7, 2013, Pages 467-481

  Needham, Brittany D ^a   Trent, M Stephen ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; ENTEROTOXIN; GLIPIZIDE; INDOLICIDIN; LIPID A; LIPOPOLYSACCHARIDE; PHOSPHOETHANOLAMINE; POLYMYXIN B; TOLL LIKE RECEPTOR 4;

BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BRONCHIECTASIS; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CELL SURVIVAL; CYSTIC FIBROSIS; ENZYME PHOSPHORYLATION; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOST RESISTANCE; HUMAN; IMMUNOSURVEILLANCE; LUNG INFECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN MODIFICATION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION; VIBRIO CHOLERAE; YERSINIA PESTIS;

ANIMALS; BACTERIAL PROTEINS; GENE EXPRESSION REGULATION, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIPID A; SIGNAL TRANSDUCTION; VIRULENCE;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 84879418353     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro3047     Document Type: Review

References (152)

1. Raetz, C. R. & Whitfield, C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71, 635-700 (2002). (Pubitemid 34800232)
2. Schneider, H. et al. Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis. Infect. Immun. 45, 544-549 (1984). (Pubitemid 14066162)
3. Nummila, K., Kilpelainen, I., Zahringer, U., Vaara, M. & Helander, I. M. Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. Mol. Microbiol. 16, 271-278 (1995).
4. Guo, L. et al. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276, 250-253 (1997). (Pubitemid 27172682)
5. Guo, L. et al. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95, 189-198 (1998). (Pubitemid 28473780)
6. Gunn, J. S. et al. PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance. Mol. Microbiol. 27, 1171-1182 (1998). (Pubitemid 28137969)
7. Raetz, C. R., Reynolds, C. M., Trent, M. S. & Bishop, R. E. Lipid A modification systems in gram-negative bacteria. Annu. Rev. Biochem. 76, 295-329 (2007).
8. Roland, K. L., Martin, L. E., Esther, C. R. & Spitznagel, J. K. Spontaneous pmrA mutants of Salmonella typhimurium LT2 define a new two-component regulatory system with a possible role in virulence. J. Bacteriol. 175, 4154-4164 (1993). (Pubitemid 23206910)
9. Miller, S. I., Kukral, A. M. & Mekalanos, J. J. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc. Natl Acad. Sci. USA 86, 5054-5058 (1989). (Pubitemid 19182231)
10. Prost, L. R. & Miller, S. I. The Salmonellae PhoQ sensor: mechanisms of detection of phagosome signals. Cell. Microbiol. 10, 576-582 (2008). (Pubitemid 351194087)
11. Gunn, J. S. The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol. 16, 284-290 (2008).
12. Fernandez, L. et al. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob. Agents Chemother. 54, 3372-3382 (2010).
13. Fernandez, L. et al. The two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRS. Antimicrob. Agents Chemother. 56, 6212-6222 (2012).
14. Llobet, E., Campos, M. A., Gimenez, P., Moranta, D. & Bengoechea, J. A. Analysis of the networks controlling the antimicrobial-peptide-dependent induction of Klebsiella pneumoniae virulence factors. Infect. Immun. 79, 3718-3732 (2011).
15. Hagiwara, D. et al. Genome-wide analyses revealing a signaling network of the RcsC-YojN-RcsB phosphorelay system in Escherichia coli. J. Bacteriol. 185, 5735-5746 (2003). (Pubitemid 37176485)
16. Eguchi, Y. et al. Signal transduction cascade between EvgA/EvgS and PhoP/PhoQ two-component systems of Escherichia coli. J. Bacteriol. 186, 3006-3014 (2004). (Pubitemid 38609743)
17. Preston, A. et al. Bordetella bronchiseptica PagP is a Bvg-regulated lipid A palmitoyl transferase that is required for persistent colonization of the mouse respiratory tract. Mol. Microbiol. 48, 725-736 (2003). (Pubitemid 36819058)
18. Gooderham, W. J. et al. The sensor kinase PhoQ mediates virulence in Pseudomonas aeruginosa. Microbiology 155, 699-711 (2009).
19. Richards, S. M., Strandberg, K. L., Conroy, M. & Gunn, J. S. Cationic antimicrobial peptides serve as activation signals for the Salmonella Typhimurium PhoPQ and PmrAB regulons in vitro and in vivo. Front. Cell. Infect. Microbiol. 2, 102 (2012).
20. 2+ as an extracellular signal: environmental regulation of Salmonella virulence. Cell 84, 165-174 (1996).
21. Kawasaki, K., Ernst, R. K. & Miller, S. I. Inhibition of Salmonella enterica serovar Typhimurium lipopolysaccharide deacylation by aminoarabinose membrane modification. J. Bacteriol. 187, 2448-2457 (2005). (Pubitemid 40389142)
22. Winfield, M. D. & Groisman, E. A. Phenotypic differences between Salmonella and Escherichia coli resulting from the disparate regulation of homologous genes. Proc. Natl Acad. Sci. USA 101, 17162-17167 (2004). (Pubitemid 39627791)
23. Moskowitz, S. M., Ernst, R. K. & Miller, S. I. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J. Bacteriol. 186, 575-579 (2004). (Pubitemid 38076447)
24. Murata, T., Tseng, W., Guina, T., Miller, S. I. & Nikaido, H. PhoPQ-mediated regulation produces a more robust permeability barrier in the outer membrane of Salmonella enterica serovar Typhimurium. J. Bacteriol. 189, 7213-7222 (2007). (Pubitemid 47557335)
25. Gunn, J. S., Ryan, S. S., Van Velkinburgh, J. C., Ernst, R. K. & Miller, S. I. Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar Typhimurium. Infect. Immun. 68, 6139-6146 (2000).
26. Ernst, R. K. et al. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 286, 1561-1565 (1999).
27. Valentin-Hansen, P., Johansen, J. & Rasmussen, A. A. Small RNAs controlling outer membrane porins. Curr. Opin. Microbiol. 10, 152-155 (2007). (Pubitemid 46590041)
28. Guillier, M., Gottesman, S. & Storz, G. Modulating the outer membrane with small RNAs. Genes Dev. 20, 2338-2348 (2006). (Pubitemid 44320382)
29. Vogel, J. & Papenfort, K. Small non-coding RNAs and the bacterial outer membrane. Curr. Opin. Microbiol. 9, 605-611 (2006). (Pubitemid 44791989)
30. Moon, K. & Gottesman, S. A PhoQ/P-regulated small RNA regulates sensitivity of Escherichia coli to antimicrobial peptides. Mol. Microbiol. 74, 1314-1330 (2009).
31. Coornaert, A. et al. MicA sRNA links the PhoP regulon to cell envelope stress. Mol. Microbiol. 76, 467-479 (2010).
32. Corcoran, C. P. et al. Superfolder GFP reporters validate diverse new mRNA targets of the classic porin regulator, MicF RNA. Mol. Microbiol. 84, 428-445 (2012).
33. Kato, A., Chen, H. D., Latifi, T. & Groisman, E. A. Reciprocal control between a bacterium's regulatory system and the modification status of its lipopolysaccharide. Mol. Cell 47, 897-908 (2012).
34. Herrera, C. M., Hankins, J. V. & Trent, M. S. Activation of PmrA inhibits LpxT-dependent phosphorylation of lipid A promoting resistance to antimicrobial peptides. Mol. Microbiol. 76, 1444-1460 (2010).
35. Eguchi, Y. et al. B1500, a small membrane protein, connects the two-component systems EvgS/EvgA and PhoQ/PhoP in Escherichia coli. Proc. Natl Acad. Sci. USA 104, 18712-18717 (2007). (Pubitemid 350210762)
36. Lippa, A. M. & Goulian, M. Feedback inhibition in the PhoQ/PhoP signaling system by a membrane peptide. PLoS Genet. 5, e1000788 (2009).
37. Bishop, R. E., Kim, S. H. & El Zoeiby, A. Role of lipid A palmitoylation in bacterial pathogenesis. J. Endotoxin Res. 11, 174-180 (2005). (Pubitemid 41131645)
38. Jia, W. et al. Lipid trafficking controls endotoxin acylation in outer membranes of Escherichia coli. J. Biol. Chem. 279, 44966-44975 (2004). (Pubitemid 39430910)
39. Bishop, R. E. Structural biology of membrane-intrinsic β-barrel enzymes: sentinels of the bacterial outer membrane. Biochim. Biophys. Acta 1778, 1881-1896 (2008).
40. Reines, M. et al. Deciphering the acylation pattern of Yersinia enterocolitica lipid A. PLoS Pathog. 8, e1002978 (2012).
41. Ausubel, F. M. Are innate immune signaling pathways in plants and animals conserved? Nature Immunol. 6, 973-979 (2005). (Pubitemid 41486181)
42. Gallo, R. L. & Hooper, L. V. Epithelial antimicrobial defence of the skin and intestine. Nature Rev. Immunol. 12, 503-516 (2012).
43. Krauel, K. et al. Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4/heparin-like epitopes. Blood 120, 3345-3352 (2012).
44. Lewis, L. A., Shafer, W. M., Dutta Ray, T., Ram, S. & Rice, P. A. Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement-killing. Infect. Immun. 81, 33-42 (2012).
45. Giangrande, C. et al. Innate immunity probed by lipopolysaccharides affinity strategy and proteomics. Anal. Bioanal. Chem. 405, 775-784 (2012).
46. Tan, L. A., Yang, A. C., Kishore, U. & Sim, R. B. Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway. Protein Cell 2, 320-332 (2011).
47. Patil, A., Hughes, A. L. & Zhang, G. Rapid evolution and diversification of mammalian α-defensins as revealed by comparative analysis of rodent and primate genes. Physiol. Genom. 20, 1-11 (2004).
48. Peschel, A. & Sahl, H. G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nature Rev. Microbiol. 4, 529-536 (2006). (Pubitemid 43905612)
49. Sassi, N., Paul, C., Martin, A., Bettaieb, A. & Jeannin, J. F. Lipid A-induced responses in vivo. A d v. Exp. Med. Biol. 667, 69-80 (2009).
50. Park, B. S. et al. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458, 1191-1195 (2009).
51. Kong, Q. et al. Palmitoylation state impacts induction of innate and acquired immunity by the Salmonella enterica serovar Typhimurium msbB mutant. Infect. Immun. 79, 5027-5038 (2011).
52. Kong, Q. et al. Phosphate groups of lipid A are essential for Salmonella enterica serovar Typhimurium virulence and affect innate and adaptive immunity. Infect. Immun. 80, 3215-3224 (2012).
53. Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B. & Miller, S. I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nature Immunol. 3, 354-359 (2002). (Pubitemid 34308623)
54. Casella, C. R. & Mitchell, T. C. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell. Mol. Life Sci. 65, 3231-3240 (2008).
55. Yamamoto, M. & Akira, S. Lipid A receptor TLR4-mediated signaling pathways. Adv. Exp. Med. Biol. 667, 59-68 (2009).
56. Mata-Haro, V. et al. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316, 1628-1632 (2007). (Pubitemid 46982038)
57. Ding, P. H., Wang, C. Y., Darveau, R. P. & Jin, L. Porphyromonas gingivalis LPS stimulates the expression of LPS-binding protein in human oral keratinocytes in vitro. Innate Immun. 19, 66-75 (2012).
58. Froelich, J. M., Tran, K. & Wall, D. A pmrA constitutive mutant sensitizes Escherichia coli to deoxycholic acid. J. Bacteriol. 188, 1180-1183 (2006). (Pubitemid 43146436)
59. Gopinath, S., Carden, S. & Monack, D. Shedding light on Salmonella carriers. Trends Microbiol. 20, 320-327 (2012).
60. Ruby, T., McLaughlin, L., Gopinath, S. & Monack, D. Salmonella's long-term relationship with its host. FEMS Microbiol. Rev. 36, 600-615 (2012).
61. Moreira, C. G. et al. Virulence and stress-related periplasmic protein (VisP) in bacterial/host associations. Proc. Natl Acad. Sci. USA 110, 1470-1475 (2013).
62. Parsonnet, J. et al. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325, 1127-1131 (1991).
63. Cullen, T. W. et al. Helicobacter pylori versus the host: remodeling of the bacterial outer membrane is required for survival in the gastric mucosa. PLoS Pathog. 7, e1002454 (2011).
64. Teghanemt, A., Zhang, D., Levis, E. N., Weiss, J. P. & Gioannini, T. L. Molecular basis of reduced potency of underacylated endotoxins. J. Immunol. 175, 4669-4676 (2005). (Pubitemid 41362008)
65. Qureshi, N., Takayama, K. & Ribi, E. Purification and structural determination of nontoxic lipid A obtained from the lipopolysaccharide of Salmonella typhimurium. J. Biol. Chem. 257, 11808-11815 (1982). (Pubitemid 13218648)
66. Raoult, D. et al. Molecular identification by "suicide PCR" of Yersinia pestis as the agent of medieval black death. Proc. Natl Acad. Sci. USA 97, 12800-12803 (2000).
67. Chouikha, I. & Hinnebusch, B. J. Yersinia-flea interactions and the evolution of the arthropod-borne transmission route of plague. Curr. Opin. Microbiol. 15, 239-246 (2012).
68. Rebeil, R. et al. Characterization of late acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation. J. Bacteriol. 188, 1381-1388 (2006). (Pubitemid 43228670)
69. Matsuura, M., Takahashi, H., Watanabe, H., Saito, S. & Kawahara, K. Immunomodulatory effects of Yersinia pestis lipopolysaccharides on human macrophages. Clin. Vaccine Immunol. 17, 49-55 (2010).
70. Montminy, S. W. et al. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nature Immunol. 7, 1066-1073 (2006). (Pubitemid 44420651)
71. Telepnev, M. V. et al. Tetraacylated lipopolysaccharide of Yersinia pestis can inhibit multiple Toll-like receptor-mediated signaling pathways in human dendritic cells. J. Infect. Dis. 200, 1694-1702 (2009).
72. Li, Y. et al. LPS remodeling is an evolved survival strategy for bacteria. Proc. Natl Acad. Sci. USA 109, 8716-8721 (2012).
73. Sherman, I. W. Twelve Diseases That Changed Our World. (American Society for Microbiology Press, 2007).
74. Gangarosa, E. J., Bennett, J. V. & Boring, J. R. III. Differentiation between Vibrio cholerae and Vibrio cholerae biotype El To r by the polymyxin B disc test: comparative results with TCBS, Monsur's, Mueller-Hinton and nutrient agar media. Bull. World Health Organ. 36, 987-990 (1967).
75. Hankins, J. V., Madsen, J. A., Giles, D. K., Brodbelt, J. S. & Trent, M. S. Amino acid addition to Vibrio cholerae LPS establishes a link between surface remodeling in Gram-positive and Gram-negative bacteria. Proc. Natl Acad. Sci. USA 109, 8722-8727 (2012).
76. Neuhaus, F. C. & Baddiley, J. A continuum of anionic charge: structures and functions of d-alanyl-teichoic acids in gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67, 686-723 (2003). (Pubitemid 37549774)
77. Munford, R. S. & Varley, A. W. Shield as signal: lipopolysaccharides and the evolution of immunity to Gram-negative bacteria. PLoS Pathog. 2, e67 (2006).
78. Vaishnava, S., Behrendt, C. L., Ismail, A. S., Eckmann, L. & Hooper, L. V. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl Acad. Sci. USA 105, 20858-20863 (2008).
79. Erwin, A. L. & Munford, R. S. Plasma lipopolysaccharide-deacylating activity (acyloxyacyl hydrolase) increases after lipopolysaccharide administration to rabbits. Lab. Invest. 65, 138-144 (1991).
80. Lu, M., Varley, A. W., Ohta, S., Hardwick, J. & Munford, R. S. Host inactivation of bacterial lipopolysaccharide prevents prolonged tolerance following Gram-negative bacterial infection. Cell Host Microbe 4, 293-302 (2008).
81. Tuin, A., Huizinga-Van der Vlag, A., van Loenen-Weemaes, A. M., Meijer, D. K. & Poelstra, K. On the role and fate of LPS-dephosphorylating activity in the rat liver. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G377-G385 (2006).
82. Koyama, I., Matsunaga, T., Harada, T., Hokari, S. & Komoda, T. Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation. Clin. Biochem. 35, 455-461 (2002). (Pubitemid 35284542)
83. Bates, J. M., Akerlund, J., Mittge, E. & Guillemin, K. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2, 371-382 (2007). (Pubitemid 350215326)
84. Rosenfeld, Y., Papo, N. & Shai, Y. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J. Biol. Chem. 281, 1636-1643 (2006).
85. Scott, A. et al. Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. PLoS ONE 6, e26525 (2011).
86. 2-glycoprotein I. Thromb. Haemost. 106, 1069-1075 (2011).
87. Agar, C. et al. beta(2)-glycoprotein I: a novel component of innate immunity. Blood 117, 6939-6947 (2011).
88. Alexander, C. & Rietschel, E. T. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 7, 167-202 (2001). (Pubitemid 32894573)
89. Vreugdenhil, A. C. et al. Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J. Immunol. 170, 1399-1405 (2003). (Pubitemid 36139507)
90. Cullen, T. W. & Trent, M. S. A link between the assembly of flagella and lipooligosaccharide of the Gram-negative bacterium Campylobacter jejuni. Proc. Natl Acad. Sci. USA 107, 5160-5165 (2010).
91. Cullen, T. W. et al. EptC of Campylobacter jejuni mediates phenotypes involved in host interactions and virulence. Infect. Immun. 81, 430-440 (2012).
92. Troy, F. A., Vijay, I. K. & Tesche, N. Role of undecaprenyl phosphate in synthesis of polymers containing sialic acid in Escherichia coli. J. Biol. Chem. 250, 156-163 (1975).
93. Bouhss, A., Trunkfield, A. E., Bugg, T. D. & Mengin-Lecreulx, D. The biosynthesis of peptidoglycan lipid-linked intermediates. FEMS Microbiol. Rev. 32, 208-233 (2008). (Pubitemid 351257812)
94. Touze, T., Tran, A. X., Hankins, J. V., Mengin-Lecreulx, D. & Trent, M. S. Periplasmic phosphorylation of lipid A is linked to the synthesis of undecaprenyl phosphate. Mol. Microbiol. 67, 264-277 (2008). (Pubitemid 350295836)
95. Coskun, U. & Simons, K. Cell membranes: the lipid perspective. Structure 19, 1543-1548 (2011).
96. Kramer, R. A. et al. Lipopolysaccharide regions involved in the activation of Escherichia coli outer membrane protease OmpT. Eur. J. Biochem. 269, 1746-1752 (2002). (Pubitemid 34304474)
97. Suomalainen, M. et al. Temperature-induced changes in the lipopolysaccharide of Yersinia pestis affect plasminogen activation by the pla surface protease. Infect. Immun. 78, 2644-2652 (2010).
98. Haurat, M. F. et al. Selective sorting of cargo proteins into bacterial membrane vesicles. J. Biol. Chem. 286, 1269-1276 (2011).
99. Kadurugamuwa, J. L. & Beveridge, T. J. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J. Bacteriol. 177, 3998-4008 (1995).
100. Mashburn, L. M. & Whiteley, M. Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature 437, 422-425 (2005). (Pubitemid 41613505)
101. Mashburn-Warren, L. et al. Interaction of quorum signals with outer membrane lipids: insights into prokaryotic membrane vesicle formation. Mol. Microbiol. 69, 491-502 (2008). (Pubitemid 351988019)
102. Spangler, B. D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56, 622-647 (1992).
103. Jansson, L., Angstrom, J., Lebens, M. & Teneberg, S. No direct binding of the heat-labile enterotoxin of Escherichia coli to E. coli lipopolysaccharides. Glycoconj. J. 27, 171-179 (2010).
104. Horstman, A. L., Bauman, S. J. & Kuehn, M. J. Lipopolysaccharide 3-deoxy-d-manno-octulosonic acid (Kdo) core determines bacterial association of secreted toxins. J. Biol. Chem. 279, 8070-8075 (2004). (Pubitemid 38294696)
105. Hajjar, A. M. et al. Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica. PLoS Pathog. 8, e1002963 (2012).
106. Kane, M. et al. Successful transmission of a retrovirus depends on the commensal microbiota. Science 334, 245-249 (2011).
107. Kuss, S. K. et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 334, 249-252 (2011).
108. O'Neill, L. A., Bryant, C. E. & Doyle, S. L. Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol. Rev. 61, 177-197 (2009).
109. Murray, G. L., Attridge, S. R. & Morona, R. Regulation of Salmonella typhimurium lipopolysaccharide O antigen chain length is required for virulence; identification of FepE as a second Wzz. Mol. Microbiol. 47, 1395-1406 (2003). (Pubitemid 36307859)
110. Zanoni, I. et al. Similarities and differences of innate immune responses elicited by smooth and rough LPS. Immunol. Lett. 142, 41-47 (2012).
111. Bogomolnaya, L. M., Santiviago, C. A., Yang, H. J., Baumler, A. J. & Andrews-Polymenis, H. L. 'Form variation' of the O12 antigen is critical for persistence of Salmonella Typhimurium in the murine intestine. Mol. Microbiol. 70, 1105-1119 (2008).
112. Kim, M. L. & Slauch, J. M. Effect of acetylation (O-factor 5) on the polyclonal antibody response to Salmonella typhimurium O-antigen. FEMS Immunol. Med. Microbiol. 26, 83-92 (1999). (Pubitemid 29475014)
113. Meredith, T. C. et al. Modification of lipopolysaccharide with colanic acid (M-antigen) repeats in Escherichia coli. J. Biol. Chem. 282, 7790-7798 (2007). (Pubitemid 47093581)
114. Gulati, S. et al. Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in gonococci. Infect. Immun. 73, 7390-7397 (2005). (Pubitemid 41587641)
115. Ram, S. et al. Heptose I glycan substitutions on Neisseria gonorrhoeae lipooligosaccharide influence C4b-binding protein binding and serum resistance. Infect. Immun. 75, 4071-4081 (2007). (Pubitemid 47206306)
116. van Vliet, S. J. et al. Variation of Neisseria gonorrhoeae lipooligosaccharide directs dendritic cell-induced T helper responses. PLoS Pathog. 5, e1000625 (2009).
117. Vacchelli, E. et al. Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy. Oncoimmunology 1, 894-907 (2012).
118. Rockwell, C. E., Morrison, D. C. & Qureshi, N. Lipid A-mediated tolerance and cancer therapy. Adv. Exp. Med. Biol. 667, 81-99 (2009).
119. Gaekwad, J. et al. Differential induction of innate immune responses by synthetic lipid a derivatives. J. Biol. Chem. 285, 29375-29386 (2010).
120. Needham, B. D. et al. Modulating the innate immune response by combinatorial engineering of endotoxin. Proc. Natl Acad. Sci. USA 110, 1464-1469 (2013).
121. Keiser, P. B. et al. A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression. Vaccine 29, 1413-1420 (2011).
122. Chen, D. J. et al. Delivery of foreign antigens by engineered outer membrane vesicle vaccines. Proc. Natl Acad. Sci. USA 107, 3099-3104 (2010).
123. Swulius, M. T. et al. Long helical filaments are not seen encircling cells in electron cryotomograms of rod-shaped bacteria. Biochem. Biophys. Res. Commun. 407, 650-655 (2011).
124. 2+ and pH in the modification of Salmonella lipid A after endocytosis by macrophage tumour cells. Mol. Microbiol. 55, 425-440 (2005). (Pubitemid 40179378)
125. Trent, M. S., Stead, C. M., Tran, A. X. & Hankins, J. V. Diversity of endotoxin and its impact on pathogenesis. J. Endotoxin Res. 12, 205-223 (2006). (Pubitemid 47470164)
126. Trent, M. S., Ribeiro, A. A., Lin, S., Cotter, R. J. & Raetz, C. R. An inner membrane enzyme in Salmonella and Escherichia coli that transfers 4-amino-4-deoxy-l-arabinose to lipid A: induction on polymyxin-resistant mutants and role of a novel lipid-linked donor. J. Biol. Chem. 276, 43122-43131 (2001).
127. McCoy, A. J., Liu, H., Falla, T. J. & Gunn, J. S. Identification of Proteus mirabilis mutants with increased sensitivity to antimicrobial peptides. Antimicrob. Agents Chemother. 45, 2030-2037 (2001). (Pubitemid 32591694)
128. Madala, N. E., Leone, M. R., Molinaro, A. & Dubery, I. A. Deciphering the structural and biological properties of the lipid A moiety of lipopolysaccharides from Burkholderia cepacia strain ASP B 2D, in Arabidopsis thaliana. Glycobiology 21, 184-194 (2011).
129. Casabuono, A. C., van der Ploeg, C. A., Roge, A. D., Bruno, S. B. & Couto, A. S. Characterization of lipid A profiles from Shigella flexneri variant X lipopolysaccharide. Rapid Commun. Mass Spectrom. 26, 2011-2020 (2012).
130. Lee, H., Hsu, F. F., Turk, J. & Groisman, E. A. The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica. J. Bacteriol. 186, 4124-4133 (2004). (Pubitemid 38802559)
131. Knirel, Y. A. et al. Cold temperature-induced modifications to the composition and structure of the lipopolysaccharide of Yersinia pestis. Carbohydr. Res. 340, 1625-1630 (2005). (Pubitemid 40798028)
132. 2+ hypersensitivity of an eptB deletion mutant. J. Biol. Chem. 280, 21202-21211 (2005). (Pubitemid 40805682)
133. Cullen, T. W., Madsen, J. A., Ivanov, P. L., Brodbelt, J. S. & Trent, M. S. Characterization of unique modification of flagellar rod protein FlgG by Campylobacter jejuni lipid A phosphoethanolamine transferase, linking bacterial locomotion and antimicrobial peptide resistance. J. Biol. Chem. 287, 3326-3336 (2012).
134. Song, F., Guan, Z. & Raetz, C. R. Biosynthesis of undecaprenyl phosphate-galactosamine and undecaprenyl phosphate-glucose in Francisella novicida. Biochemistry 48, 1173-1182 (2009).
135. Soni, S. et al. Francisella tularensis blue-gray phase variation involves structural modifications of lipopolysaccharide O-antigen, core and lipid A and affects intramacrophage survival and vaccine efficacy. Front. Microbiol. 1, 129 (2010).
136. White, K. A., Lin, S., Cotter, R. J. & Raetz, C. R. A Haemophilus influenzae gene that encodes a membrane bound 3-deoxy-d-manno-octulosonic acid (Kdo) kinase. Possible involvement of kdo phosphorylation in bacterial virulence. J. Biol. Chem. 274, 31391-31400 (1999).
137. Chalabaev, S., Kim, T. H., Ross, R., Derian, A. & Kasper, D. L. 3-Deoxy-d-manno-octulosonic acid (Kdo) hydrolase identified in Francisella tularensis, Helicobacter pylori, and Legionella pneumophila. J. Biol. Chem. 285, 34330-34336 (2010).
138. Stead, C. M., Zhao, J., Raetz, C. R. & Trent, M. S. Removal of the outer Kdo from Helicobacter pylori lipopolysaccharide and its impact on the bacterial surface. Mol. Microbiol. 78, 837-852 (2010).
139. Zhao, J. & Raetz, C. R. A two-component Kdo hydrolase in the inner membrane of Francisella novicida. Mol. Microbiol. 78, 820-836 (2010).
140. Chung, H. S. & Raetz, C. R. Dioxygenases in Burkholderia ambifaria and Yersinia pestis that hydroxylate the outer Kdo unit of lipopolysaccharide. Proc. Natl Acad. Sci. USA 108, 510-515 (2011).
141. Boon Hinckley, M. et al. A Leptospira interrogans enzyme with similarity to yeast Ste14p that methylates the 1-phosphate group of lipid A. J. Biol. Chem. 280, 30214-30224 (2005).
142. Karbarz, M. J., Kalb, S. R., Cotter, R. J. & Raetz, C. R. Expression cloning and biochemical characterization of a Rhizobium leguminosarum lipid A 1-phosphatase. J. Biol. Chem. 278, 39269-39279 (2003). (Pubitemid 37248481)
143. Wang, X., McGrath, S. C., Cotter, R. J. & Raetz, C. R. Expression cloning and periplasmic orientation of the Francisella novicida lipid A 4-phosphatase LpxF. J. Biol. Chem. 281, 9321-9330 (2006). (Pubitemid 43864648)
144. Coats, S. R., To, T. T., Jain, S., Braham, P. H. & Darveau, R. P. Porphyromonas gingivalis resistance to polymyxin B is determined by the lipid A 4-phosphatase, PGN-0524. Int. J. Oral Sci. 1, 126-135 (2009).
145. Gibbons, H. S., Reynolds, C. M., Guan, Z. & Raetz, C. R. An inner membrane dioxygenase that generates the 2-hydroxymyristate moiety of Salmonella lipid A. Biochemistry 47, 2814-2825 (2008). (Pubitemid 351328832)
146. Carty, S. M. Sreekumar, K. R. & Raetz, C. R. Effect of cold shock on lipid A biosynthesis in Escherichia coli induction at 12 °C of an acyltransferase specific for palmitoleoyl-acyl carrier protein. J. Biol. Chem. 274, 9677-9685 (1999).
147. Soderberg, M. A. & Cianciotto, N. P. Mediators of lipid A modification, RNA degradation, and central intermediary metabolism facilitate the growth of Legionella pneumophila at low temperatures. Curr. Microbiol. 60, 59-65 (2010).
148. Reynolds, C. M. et al. An outer membrane enzyme encoded by Salmonella typhimurium lpxR that removes the 3-acyloxyacyl moiety of lipid A. J. Biol. Chem. 281, 21974-21987 (2006). (Pubitemid 44181901)
149. Trent, M. S., Pabich, W., Raetz, C. R. & Miller, S. I. A PhoP/PhoQ-induced lipase (PagL) that catalyzes 3-O-deacylation of lipid A precursors in membranes of Salmonella typhimurium. J. Biol. Chem. 276, 9083-9092 (2001).
150. Bishop, R. E. et al. Transfer of palmitate from phospholipids to lipid A in outer membranes of Gram-negative bacteria. EMBO J. 19, 5071-5080 (2000).
151. Fukuoka, S. et al. Physico-chemical and biophysical study of the interaction of hexa-and heptaacyl lipid A from Erwinia carotovora with magainin 2-derived antimicrobial peptides. Biochim. Biophys. Acta 1778, 2051-2057 (2008).
152. Clements, A. et al. Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides. J. Biol. Chem. 282, 15569-15577 (2007). (Pubitemid 47093289)